Mission Wealth Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-40,000
Closed -$211K 632
2024
Q3
$211K Buy
+40,000
New +$211K 0.01% 600